- Investing Ideas
- /
- Bangladeshi Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Bangladeshi Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
Renata
Market Cap: ৳55.2b
Manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh.
RENATA
৳481.20
7D
-0.7%
1Y
-24.6%
IBN SINA Pharmaceutical Industry
Market Cap: ৳9.0b
Produces and sells pharmaceutical drugs in Bangladesh and internationally.
IBNSINA
৳287.90
7D
2.3%
1Y
19.7%